Investment Summary |
|
|---|---|
| Date | 2017-01-01 |
| Target | Trilogy MedWaste |
| Sector | Environmental |
| Investor(s) | KKR |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 267.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 222 of 500 |
| Sector: Environmental M&A | 5 of 13 |
| Type: Growth Capital M&A Deals | 34 of 82 |
| State: Texas M&A | 14 of 27 |
| Country: United States M&A | 93 of 212 |
| Year: 2017 M&A | 2 of 41 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
Ajax Health
Menlo Park, California, United States Ajax focuses on accelerating innovative medical device technology opportunities that address significant unmet clinical needs. Ajax Health was formed in 2017 and is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-02 |
BridgeBio
Palo Alto, California, United States BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California. |
Buy | - |
